Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gateways to clinical trials.

M Bayes1, X Rabasseda, J R Prous

  • 1Prous Science, S.A., Barcelona, Spain. mbayes@prous.com

Methods and Findings in Experimental and Clinical Pharmacology
|August 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the American Association of Urology Annual Meeting 2015 (May 15-19 - New Orleans, Louisiana, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 73rd Annual Meeting of the American Academy of Dermatology (March 20-24 - San Francisco, California, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the European Association for the Study of the Liver's 50th International Liver Congress (April 22-26 - Vienna, Austria).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (November 14-19 - Boston, Massachusetts, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

This guide presents recent clinical trials for numerous drugs, including Adalimumab and Bortezomib. It offers a comprehensive overview of ongoing research and development in pharmaceutical science.

Area of Science:

  • Pharmaceutical Science
  • Clinical Research
  • Drug Discovery and Development

Context:

  • Gateways to Clinical Trials provides a curated selection of the latest clinical trials from current literature and congresses.
  • Data is sourced from the Clinical Studies Knowledge Area of Prous Science Integrity, a dedicated drug discovery and development portal.
  • This issue highlights a diverse range of therapeutic agents, spanning various stages of clinical investigation.

Purpose:

  • To offer a comprehensive overview of recent advancements in clinical trials across a wide spectrum of pharmaceutical agents.
  • To serve as a valuable resource for researchers, clinicians, and industry professionals tracking drug development progress.
  • To consolidate information on emerging therapies and investigational drugs for enhanced accessibility.

Summary:

Related Experiment Videos

  • The publication details clinical trial information for an extensive list of drugs, including but not limited to Adalimumab, Bortezomib, Everolimus, Imatinib Mesylate, and Voriconazole.
  • It covers trials for novel compounds and established medications undergoing further investigation, such as Adenosine Triphosphate, Albumin Interferon Alfa, and Peginterferon Alfa.
  • The selection encompasses agents targeting a broad array of medical conditions, reflecting the dynamic nature of pharmaceutical research.

Impact:

  • Facilitates informed decision-making for healthcare professionals and researchers by providing timely clinical trial data.
  • Supports the acceleration of drug discovery and development pipelines through accessible research summaries.
  • Enhances understanding of the therapeutic landscape and potential new treatment options emerging from clinical studies.